Cognizant revolutionizes AI with new multi-agent orchestration!

Cognizant revolutionizes AI with new multi-agent orchestration!

Cognizant, a leading digital services company based in Teaneck, New Jersey, recently announced significant innovations for its Neuro® AI platform. This update enables companies to more effectively harness the power of artificial intelligence (AI) to improve business decisions and create new revenue streams.

The new multi-agent orchestration of the Neuro® AI platform is intended to make a decisive contribution to increasing productivity. According to a study conducted with Oxford Economics, 76% of companies are interested in using AI to increase revenue, but the majority struggle to implement and scale solutions. The update aims to address this challenge and enables executives to make decisions and generate corresponding predictions in minutes.

Innovations for numerous industries

Cognizant's expanded platform is now available to all customers and has already received positive feedback. With more than a hundred tested applications, the platform can be used in a variety of ways - be it in agriculture, healthcare or the financial industry. Leading companies such as Gilead Sciences and Bayer Crop Science have described the improvements as groundbreaking. Gilead said the new platform will help significantly improve decision-making in complex business environments. Particular emphasis is placed on multi-agent technology, which makes it possible to coordinate and optimize multiple decision-making algorithms at the same time.

The Opportunity Finder, a new tool in the platform, helps companies identify potential applications of AI, while a drag-and-drop user interface makes it easier for users to prepare data sets for machine learning. This greatly simplifies the process and significantly reduces the time required to analyze data, which Cognizant says represents realistic opportunities to quickly implement AI solutions.

The Neuro® AI platform also offers solutions in agriculture, where the challenges posed by environmental factors and social contexts are particularly great. Bayer Crop Science has praised the platform's ability to reliably handle complex decision-making scenarios while supporting innovative approaches to decision-making.

Babak Hodjat, the chief technology officer for AI at Cognizant, commented that many companies struggle to fully realize the benefits of AI and that application scenarios often remain limited to simple predictive models. The Neuro® AI platform's multi-agent approach removes these barriers and helps companies view their data from different perspectives to develop comprehensive solutions.

The market specifically for AI applications is growing rapidly, and the use of multi-agent systems is recognized as an important factor in creating effective and scalable solutions. According to Gartner, multiple agents can work together to go beyond the capabilities of individual agents. This could be crucial for companies seeking to reduce the complexity of their business decisions using AI.

These enhancements are important not only for large enterprises, but also for small and medium-sized businesses that may be at the beginning of their AI journey. Using easily accessible tools to quickly identify use cases could help these companies better compete and develop innovative solutions.

To learn more about the advanced features of the Cognizant Neuro® AI platform and to book a demo, interested parties can visit the Cognizant website. Information on the diverse possible uses, from drug development to optimizing logistical processes, is also available there.